Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-059624
Filing Date
2006-11-15
Accepted
2006-11-15 17:48:24
Documents
1
Period of Report
2006-11-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf25269_bsf1el.html 4  
1 MAIN DOCUMENT DESCRIPTION bsf25269_bsf1el.xml 4 27674
  Complete submission text file 0001209191-06-059624.txt   29590
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO BIOSCIENCES IN STE.A-100 POINT RICHMOND TECH CENTER 501 CANA BLVD RICHMOND CA 94804
Business Address 415-442-1429
LANPHIER EDWARD O II (Reporting) CIK: 0001234386 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 061221032